Sinco Pharmaceuticals Holdings Limited (HKG:6833)
0.1710
+0.0010 (0.59%)
Jun 8, 2026, 3:00 PM HKT
HKG:6833 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 346 | 360 | 400 | 488 | 539 | 3,517 | |
Market Cap Growth | 1.80% | -10.15% | -17.92% | -9.43% | -84.68% | 604.67% |
Enterprise Value | 272 | 355 | 457 | 153 | 405 | 3,596 |
Last Close Price | 0.17 | 0.18 | 0.19 | 0.23 | 0.25 | 1.77 |
PE Ratio | 8.99 | 9.28 | 8.95 | 10.46 | 6.86 | 21.21 |
Forward PE | - | 15.28 | 15.28 | 15.28 | 15.28 | 15.28 |
PS Ratio | 0.15 | 0.16 | 0.13 | 0.17 | 0.21 | 1.42 |
PB Ratio | 0.45 | 0.47 | 0.57 | 0.71 | 0.79 | 7.64 |
P/TBV Ratio | 0.50 | 0.52 | 0.64 | 0.81 | 0.91 | 7.64 |
P/FCF Ratio | 1.57 | 1.64 | - | 1.37 | 21.28 | 10.15 |
P/OCF Ratio | 1.50 | 1.56 | - | 1.25 | 6.35 | 9.37 |
EV/Sales Ratio | 0.12 | 0.15 | 0.15 | 0.06 | 0.16 | 1.45 |
EV/EBITDA Ratio | 2.44 | 3.41 | 3.24 | 1.09 | 3.29 | 14.82 |
EV/EBIT Ratio | 3.28 | 4.27 | 3.77 | 1.20 | 3.54 | 15.21 |
EV/FCF Ratio | 1.24 | 1.61 | - | 0.43 | 15.99 | 10.38 |
Debt / Equity Ratio | 0.26 | 0.26 | 0.53 | 0.40 | 0.32 | 0.91 |
Debt / EBITDA Ratio | 1.83 | 1.83 | 2.53 | 1.89 | 1.71 | 1.71 |
Debt / FCF Ratio | 0.93 | 0.93 | - | 0.78 | 8.59 | 1.21 |
Net Debt / Equity Ratio | -0.09 | -0.09 | 0.06 | -0.30 | -0.23 | 0.04 |
Net Debt / EBITDA Ratio | -0.70 | -0.70 | 0.32 | -1.46 | -1.25 | 0.08 |
Net Debt / FCF Ratio | -0.33 | -0.33 | -0.16 | -0.57 | -6.11 | 0.05 |
Asset Turnover | 1.08 | 1.08 | 1.45 | 1.53 | 1.71 | 1.63 |
Inventory Turnover | 6.09 | 6.09 | 10.95 | 22.44 | 25.81 | 10.87 |
Quick Ratio | 0.78 | 0.78 | 0.74 | 0.84 | 0.91 | 0.76 |
Current Ratio | 1.18 | 1.18 | 1.14 | 1.16 | 1.29 | 1.34 |
Return on Equity (ROE) | 5.14% | 5.14% | 6.51% | 6.88% | 14.19% | 50.09% |
Return on Assets (ROA) | 2.43% | 2.43% | 3.66% | 4.39% | 4.76% | 9.69% |
Return on Invested Capital (ROIC) | 8.58% | 8.09% | 8.45% | 10.87% | 16.53% | 63.09% |
Return on Capital Employed (ROCE) | 10.70% | 10.70% | 17.00% | 17.70% | 16.00% | 38.00% |
Earnings Yield | 11.22% | 10.78% | 11.17% | 9.56% | 14.58% | 4.71% |
FCF Yield | 63.61% | 61.10% | -71.22% | 73.19% | 4.70% | 9.85% |
Dividend Yield | 1.01% | 0.95% | 1.04% | 1.69% | 3.96% | - |
Payout Ratio | 10.53% | 10.53% | 17.17% | 42.77% | - | - |
Buyback Yield / Dilution | - | - | - | -0.07% | -16.93% | -2.69% |
Total Shareholder Return | 1.01% | 0.95% | 1.04% | 1.62% | -12.97% | -2.69% |